Five Valsartan Lawsuits Selected for Second Round of Bellwether Trials
Selections have been made in case the parties fail to negotiate Valsartan cancer settlements following a first round of bellwether trials expected to begin in late 2025.
Selections have been made in case the parties fail to negotiate Valsartan cancer settlements following a first round of bellwether trials expected to begin in late 2025.
Five women out of every 100 that drink more than two drinks per day will develop breast cancer, U.S. health officials warn.
L'Oreal faces six class action lawsuits over CeraVe and other popular acne treatments, which allegedly exposed consumers to high levels of cancer-causing benzene.
Proposed rule comes as Johnson & Johnson continues to face tens of thousands of Johnson's Baby Powder lawsuits alleging asbestos in the talc-based powder caused cancer
Researchers identified 31 carcinogens that firefighters are regularly exposed to while fighting wildfires.
Residents may not know for years that they were exposed to PFAS or the injuries that it caused, lawmakers argue.
Court has given the parties until January 3 to submit their competing plans for hair relaxer lawsuit bellwether trial protocols.
Lawsuits allege recalled BioZorb Markers failed to absorb after breast cancer treatments, resulting in painful complications and need for additional surgery.
Legislation has already been introduced to ban red food dyes in several U.S. states, including California, Illinois and New York.
Manufacturers failed to turn over complete lists of hair relaxer brand names, when they were sold, and what toxic ingredients each contained, plaintiffs say.